comprehensive -WSS

comprehensive

author：focus 2025-09-27 09:54:56 - browse：384

a liver made up by geometric shapes – biotech coverage from STAT — Adobe

Intercept Pharmaceuticals, a firm whose treatment for a prevalent liver disease once made it the hottest stock in biotech, said Tuesday it would sell the company for less than $1 billion.

Alfasigma, an Italian pharmaceutical firm, will pay $19 a share for Intercept, in a roughly $800 million cash deal that represents an 80% premium to the company’s recent trading price. Intercept expects the deal to close by the end of the year.

The transaction comes three months after the Food and Drug Administration rejected Intercept’s treatment for NASH, an increasingly common fatty liver disease perceived as a potential gold mine by drug companies. Intercept’s medicine, called obeticholic acid, would have been the first approved treatment for NASH, but serious concerns about the risk of drug-related liver damage and uncertainty over whether its modest effects would improve patients’ lives made it unapprovable in the eyes of the FDA.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： New warning issued for rebooking air travel after delays, cancellations

knowledge

WSS

How dance can help health care workers heal from trauma

Trump got a 'target letter.' What is one and what does it mean?

Norman Reedus' Daryl Dixon

American taxpayers paid $1.8 trillion in health care costs in 2022

Ascension's ugly legal battle over care for poor patients in Texas

'Reaching a detente': STAT's Helen Branswell on covering Covid

explore

comprehensive

entertainment

New air purifier tech could be key to improving indoor air quality

Merck to acquire Harpoon Therapeutics for $680 million

Affirmative action in medical school literally saved lives

JPM pitch from hospitals? Revenue streams outside of patient care

Jerome Adams on the need for new antivirals for Covid

'Reaching a detente': STAT's Helen Branswell on covering Covid

Medical records are filled with copy

American taxpayers paid $1.8 trillion in health care costs in 2022

United colonoscopy coverage change 'may cost lives,' doctors say

Researchers separate signal from noise in heart wearable data

explore

Medicare Advantage coverage denials need scrutiny, senators say

Gene therapy denied for Afghan refugee whose father aided U.S.

Researchers separate signal from noise in heart wearable data

Fauci's latest grilling in Congress: 9 hours, behind closed doors

DOJ, FTC to increase scrutiny of all types of health care mergers

Stanford president to resign after investigation of research

knowledge

hotspot

entertainment

focus